Lucy Scientific Discovery... (LSDI)
0.51
-0.00 (-0.76%)
At close: Jun 28, 2024, 8:00 PM
0.46
-11.42%
After-hours: Jun 28, 2024, 07:59 PM EDT
Company Description
Lucy Scientific Discovery Inc. researches, develops, manufactures, and commercializes psychedelic products.
It offers biological raw materials, crude extracts, psychotropic compounds, and active pharmaceutical ingredients (APIs).
Lucy Scientific Discovery Inc. was formerly known as Hollyweed North Cannabis, Inc.
The company was incorporated in 2017 and is based in Victoria, Canada.
Lucy Scientific Discovery Inc.
| Country | CA |
| IPO Date | Feb 9, 2023 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 2 |
| CEO | Richard D. Nanula |
Contact Details
Address: Blanshard Street Victoria, BC CA | |
| Website | https://www.lucyscientific.com |
Stock Details
| Ticker Symbol | LSDI |
| Exchange | NASDAQ |
| Fiscal Year | July - June |
| Reporting Currency | USD |
| CIK Code | 0001865127 |
| CUSIP Number | n/a |
| ISIN Number | CA54960E2033 |
| Employer ID | 00-0000000 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Richard D. Nanula | Chief Executive Officer & Executive Chair |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 02, 2025 | SCHEDULE 13G/A | [Amend] Filing |
| Nov 12, 2024 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Sep 06, 2024 | 25-NSE | Filing |
| Jul 01, 2024 | 8-K | Current Report |
| May 28, 2024 | 8-K | Current Report |
| May 15, 2024 | NT 10-Q | Filing |
| May 09, 2024 | 8-K | Current Report |
| Apr 23, 2024 | 8-K | Current Report |
| Mar 12, 2024 | 8-K | Current Report |
| Mar 01, 2024 | 424B3 | Filing |